Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis
- PMID: 20022081
- PMCID: PMC2851158
- DOI: 10.1016/j.thromres.2009.11.028
Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis
Abstract
Factor XII (FXII) is a coagulation protein that is essential for surface-activated blood coagulation tests but whose deficiency is not associated with bleeding. For over forty years, investigators in hemostasis have not considered FXII important because its deficiency is not associated with bleeding. It is because there is a dichotomy between abnormal laboratory assay findings due to FXII deficiency and clinical hemostasis that investigators sought explanations for physiologic hemostasis independent of FXII. FXII is a multidomain protein that contains two fibronectin binding consensual sequences, two epidermal growth factor regions, a kringle region, a proline-rich domain, and a catalytic domain that when proteolyzed turns into a plasma serine protease. Recent investigations with FXII deleted mice that are protected from thrombosis indicate that it contributes to the extent of developing thrombus in the intravascular compartment. These findings suggest that it has a role in thrombus formation without influencing hemostasis. Last, FXII has been newly appreciated to be a growth factor that may influence tissue injury repair and angiogenesis. These combined studies suggest that FXII may become a pharmacologic target to reduce arterial thrombosis risk and promote cell repair after injury, without influencing hemostasis.
(c) 2009 Elsevier Ltd. All rights reserved.
Figures

Similar articles
-
Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.J Exp Med. 2006 Mar 20;203(3):513-8. doi: 10.1084/jem.20052458. Epub 2006 Mar 13. J Exp Med. 2006. PMID: 16533887 Free PMC article.
-
The intrinsic pathway of coagulation is essential for thrombus stability in mice.Blood Cells Mol Dis. 2006 Mar-Apr;36(2):148-51. doi: 10.1016/j.bcmd.2005.12.014. Epub 2006 Feb 8. Blood Cells Mol Dis. 2006. PMID: 16466946
-
In vivo roles of factor XII.Blood. 2012 Nov 22;120(22):4296-303. doi: 10.1182/blood-2012-07-292094. Epub 2012 Sep 19. Blood. 2012. PMID: 22993391 Free PMC article. Review.
-
Role of Factor XII in hemostasis and thrombosis: clinical implications.Expert Rev Cardiovasc Ther. 2007 Jul;5(4):733-41. doi: 10.1586/14779072.5.4.733. Expert Rev Cardiovasc Ther. 2007. PMID: 17605651 Review.
-
Factor XII inhibition reduces thrombus formation in a primate thrombosis model.Blood. 2014 Mar 13;123(11):1739-46. doi: 10.1182/blood-2013-04-499111. Epub 2014 Jan 9. Blood. 2014. PMID: 24408325 Free PMC article.
Cited by
-
Incorporation of Evidence-based Guidelines on Bleeding Risk Assessment Prior to Surgery into Practice: Real-time Experience.Oman Med J. 2022 Jan 31;37(1):e346. doi: 10.5001/omj.2022.35. eCollection 2022 Jan. Oman Med J. 2022. PMID: 35282424 Free PMC article.
-
Hereditary factor XII deficiency in an adult patient: A case report.SAGE Open Med Case Rep. 2022 Aug 17;10:2050313X221118728. doi: 10.1177/2050313X221118728. eCollection 2022. SAGE Open Med Case Rep. 2022. PMID: 36003888 Free PMC article.
-
The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities.Ann Transl Med. 2015 Oct;3(17):247. doi: 10.3978/j.issn.2305-5839.2015.09.07. Ann Transl Med. 2015. PMID: 26605293 Free PMC article. Review.
-
Histidine-rich glycoprotein attenuates catheter thrombosis.Blood Adv. 2023 Sep 26;7(18):5651-5660. doi: 10.1182/bloodadvances.2022009236. Blood Adv. 2023. PMID: 37042966 Free PMC article.
-
Contact activation of coagulation in newly inserted indwelling catheters.Sci Rep. 2025 Jun 3;15(1):19378. doi: 10.1038/s41598-025-04181-3. Sci Rep. 2025. PMID: 40461568 Free PMC article.
References
-
- Davie EW, Ratnoff OD. Waterfall Sequence for Intrinsic Blood Clotting. Science. 1964 Sep;18(145):1310–1312. - PubMed
-
- Citarella F, Tripodi M, Fantoni A, Bernardi F, Romeo G, Rocchi M. Assignment of human coagulation factor XII (fXII) to chromosome 5 by cDNA hybridization to DNA from somatic cell hybrids. Hum Genet. 1988 Dec;80(4):397–398. - PubMed
-
- Cool DE, MacGillivray RT. Characterization of the human blood coagulation factor XII gene. Intron/exon gene organization and analysis of the 5'-flanking region. J Biol Chem. 1987 Oct 5;262(28):13662–13673. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical